Management of Drug Interactions With Nirmatrelvir/Ritonavir (Paxlovid®): Resource for Clinicians – Infectious Diseases Society of America Commentary: IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir – ACP Internist Related: Paxlovid’s failure as a preventative measure raises questions, but doctors still back it as a therapeutic – STAT Yes, Relapses After Paxlovid Happen — Now What? […]

The post Management of drug interactions with Nirmatrelvir/Ritonavir (Paxlovid). appeared first on Links Medicus.